Sutro slashes workforce in half, changes CEO and closes factorynews2025-03-14T12:32:54+00:00March 14th, 2025|Endpoints News|
MoonLake’s CEO on its looming mid-year pivotal readout in skin diseasenews2025-03-14T09:05:36+00:00March 14th, 2025|Endpoints News|
Pfizer terminates an early-stage STING agonist trialnews2025-03-14T07:54:55+00:00March 14th, 2025|Endpoints News|
Updated: White House pulls Weldon’s nomination to lead CDCnews2025-03-13T13:09:55+00:00March 13th, 2025|Endpoints News|
Amgen reports more Phase 3 Uplizna data in myasthenia gravis ahead of FDA filingnews2025-03-13T11:22:19+00:00March 13th, 2025|Endpoints News|
Why Gilead could lose its HIV product hopping casenews2025-03-12T18:52:24+00:00March 12th, 2025|Endpoints News|
Viking Therapeutics taps CordenPharma to manufacture its obesity drugsnews2025-03-12T13:43:22+00:00March 12th, 2025|Endpoints News|
Legend to double Carvykti production as it targets blockbuster status news2025-03-12T11:19:37+00:00March 12th, 2025|Endpoints News|
Merck dodges ‘failure to warn’ claims in federal Gardasil casesnews2025-03-11T17:39:19+00:00March 11th, 2025|Endpoints News|
Corrected: Merck opens billion-dollar US facility to make Gardasilnews2025-03-11T13:50:06+00:00March 11th, 2025|Endpoints News|
